A Study of Biochemical Markers in Uterine Cancer Diagnosis with Radiotherpay Treatment In Iraq
Wael Sahib Alnweny 1*, Mohammed Q. Almayali 1*, Mohammed A. Dakhil 2, Hiba Ali Numan 1, Yasir J. Abbas 3
Journal of Angiotherapy 8(3) 1-8 https://doi.org/10.25163/angiotherapy.839614
Submitted: 15 January 2024 Revised: 12 March 2024 Published: 19 March 2024
Abstract
Background: Uterine cancer is a prevalent gynecological malignancy, with rising incidence rates globally. Early detection and effective treatment are essential for improving patient outcomes. Biochemical markers play a crucial role in diagnosing and monitoring uterine cancer, yet their comprehensive evaluation remains limited. Methods: This study aimed to assess various biochemical markers in the serum of uterine cancer patients compared to healthy individuals. Serum samples from 30 uterine cancer patients and 40 healthy females were analyzed for urea, creatinine, lactate dehydrogenase (LDH) activity, antioxidants (vitamin C and vitamin E), peroxynitrite, and trace elements (calcium and zinc). Results: The study revealed a significant decrease in urea and creatinine levels in serum of uterine cancer patients compared to healthy individuals (p≤0.05). During radiotherapy, blood urea nitrogen (BUN) exceeded the normal range (7-20 mg/dl), averaging 25.44 ± 9.87 mg/dl before treatment initiation, with no significant decrease during therapy. Serum creatinine levels remained within the normal range. Additionally, a significant reduction in serum vitamin C and vitamin E levels was observed in uterine cancer patients compared to healthy individuals (p≤0.05). Moreover, there was a significant increase in peroxynitrite and lactate dehydrogenase (LDH) activity, along with a rise in serum calcium levels, and a significant decrease in serum zinc levels among uterine cancer patients (p≤0.05). Conclusion: The findings highlight the significance of assessing multiple biochemical markers in uterine cancer diagnosis and monitoring. Elevated LDH, peroxynitrite, and calcium levels, along with reduced vitamin C, vitamin E, and zinc levels, may serve as valuable diagnostic markers for uterine cancer.
Keywords: Radiotherapy; Biochemical parameters; Uterine Cancer, Diagnosis, Risk Factors, Treatment
References
Abu-Rustum, N. R., Zhou, Q., Iasonos, A., Alektiar, K. M., Leitao, M. M., Chi, D. S., ... & Barakat, R. R. (2011). The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?. International Journal of Gynecologic Cancer, 21(3).
Bandera, E.V.; Gifkins, D.M.; Moore, D.F.; McCullough, M.L.; Kushi, L.H. (2009). Antioxidant vitamin and the risk of endometrial cancer adose-response metaanalysis. Cancer Causes and Control, 20(5), 699-711.
Beerheide, W.; Bernard, H.; Tan, Y.; Ganesan, A.; Rice, W.; Ting, A. (1990). Potential
Bhuvarahamurthy, V.; Balasubramanian, N.; Govindasamy, S. (1996). Effect of
Block, G. (1992). Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr Cancer, 18 (1), 1-29. Buchanan, E.M.; Weinstein, L.C.; Hillson, C. (2009). Endometrial cancer. Am. Fam. Physician, 80(10), 1075-1080.
Boeckstaens, S., Dewalheyns, S., Heremans, R., Vikram, R., Timmerman, D., Van den Bosch, T., & Verbakel, J. Y. (2020). Signs and symptoms associated with uterine cancer in pre-and postmenopausal women. Heliyon, 6(11).
Boggess, J. F., Kilgore, J. E., & Tran, A. Q. (2020). Uterine cancer. In Abeloff's Clinical Oncology (pp. 1508-1524). Elsevier.
Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecologic oncology, 15(1), 10-17.
Chen, L. M., Yang, P. P., Al Haq, A. T., Hwang, P. A., Lai, Y. C., Weng, Y. S., ... & Hsu, H. L. (2022). Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice. Journal of Biomedical Science, 29(1), 70.
Clarke, M. A., Long, B. J., Morillo, A. D. M., Arbyn, M., Bakkum-Gamez, J. N., & Wentzensen, N. (2018). Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA internal medicine, 178(9), 1210-1222.
Cobbs, C.S.; Whisenhunt, T.R.; Wesemann, D.R.; Harkins, L.E.; Van Meir, E.G.; Samanta, M.(2003). Inactivation of Wild- Type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Can. Res., 63, 8670- 8673.
Devi, L. I., Ralte, L., & Ali, M. A. (2015). Serum biochemical profile of breast cancer patients. European Journal of Pharmaceutical and Medical Research, 2(6), 210-214.
drugs against cervical cancer. Zinc- ejecting inhibitors of the human papillomavirus Type 16E 6 oncoprotein. J. Formos Med. Assoc. Aug., 8, 677- 82.
Felix, A. S., Weissfeld, J. L., Stone, R. A., Bowser, R., Chivukula, M., Edwards, R. P., & Linkov, F. (2010). Factors associated with Type I and Type II endometrial cancer. Cancer Causes & Control, 21, 1851-1856.
Head, K. A. (1998). Ascorbic acid in the prevention and treatment of cancer. Altern Med Rev, 3(3), 174-186.
Karaca, F., Mentes, S., & Keskin, S. (2018). Evaluation of hematologic and biochemical parameters in patients with early stage uterine malignancy receiving radiotherapy. Eastern Journal of Medicine, 23(3).
Kimura, T., Kamiura, S., Yamamoto, T., Seino-Noda, H., Ohira, H., & Saji, F. (2004). Abnormal uterine bleeding and prognosis of endometrial cancer. International Journal of Gynecology & Obstetrics, 85(2), 145-150.
Kumar, M.; Birdi, A.; Gupta, Y.N.; Gupta, S. (1988). Serum lactate dehydrogenase isoenzymes alternation in carcinoma cervix uteri. Int. J. Gynaecol. Obset., 27(1), 91- 95.
M Bilal, K. (2013). Measurement of some biochemical parameters in serum of uterine cancer. Rafidain journal of science, 24(11), 37-44.
Manju, V.; Sailaja, J.K.; Nalini, N. (2002). Circulating lipid peroxidation and antioxidant status in cervical cancer patients: acase- control study. Clinical Biochemistry, 35(8), 621- 625.
Merritt, L. L., Dean, J. A., & Willard, H. H. (Eds.). (1974). Instrumental methods of analysis. D. Van Nostrand Company.
Naidu, M.S.; Suryakar, A.N.; Swami, S.C.; Katkam, R.V.; Kumbar, K.M. (2007). Oxidative stress and antioxidant status in cervical cancer patients. Indian J. Clinical Biochemistry, 22(2), 140- 144.
Niki, E. (1991). Action of ascorbic acid as a scavenger of active and stable oxygen radicals. The American journal of clinical nutrition, 54(6), 1119S-1124S.
Pozzar, R. A., Hammer, M. J., Cooper, B. A., Kober, K. M., Chen, L. M., Paul, S. M., ... & Miaskowski, C. (2022). Stability of symptom clusters in patients with gynecologic cancer receiving chemotherapy. Cancer nursing, 45(4), E706-E718.
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., ... & Sirchia, G. (2002). Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of internal medicine, 137(1), 1-10.
radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Molecular and cellular Biochemistry, 158, 17- 23.
Rijke, D.; Trienekens, P.H. (1985). Variant expression of lactate dehydrogenase complex, interfering with isoenzyme analysis. Clin. Chem. Acta., 146, 135.
Schmeler, K. M., Soliman, P. T., Sun, C. C., Slomovitz, B. M., Gershenson, D. M., & Lu, K. H. (2005). Endometrial cancer in young, normal-weight women. Gynecologic oncology, 99(2), 388-392.
Seebacher, V., Schmid, M., Polterauer, S., Hefler-Frischmuth, K., Leipold, H., Concin, N., ... & Hefler, L. (2009). The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC cancer, 9, 1-5.
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: a cancer journal for clinicians, 69(1), 7-34.
Smith, R. A., von Eschenbach, A. C., Wender, R., Levin, B., Byers, T., Rothenberger, D., ... & Eyre, H. (2001). American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: Also: update 2001—testing for early lung cancer detection. CA: a cancer journal for clinicians, 51(1), 38-75.
ST, O. (1979). Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids: Ascorbic acid analysis II. Determination. After derivatization with 2, 4-dinitrophenylhydrazine. Method Enzymol, 62, 3-11.
Stahl, W.; Sies, H. (1997). Antioxidant defense vitamins E and C and carotnoids. Diabetes, 46, 14- 18.
Subramanian, N.; Krishnan, H.M.; Venkatachalam, P.; Kamatchi, P.A.C. (2009). A study of lactate dehydrogenase (LDH) isoenzyme is a biochemical tumor marker in cervical carcinoma patients. Int. J. Hum. Genet, 9(1), 5- 12.
Thomas, J. H., & Gillham, B. (2013). Wills' biochemical basis of medicine. Elsevier.
Tietz, N.W. (1976). "Fundamentals of Clinical Chemistry". W. B. Saunders Company, Philadelphia.
Vanuffelen, B.E.; Van Derzec, J.; Dekoster, B.M. (1998). Biochem. J., pp.330-719 cited by Al-Zamely, O.M.; Al-Nimer, M.S.; Muslih, R.K. (2001). Detection the level of peroxy nitrite and related with antioxidant status in the serum of patient with acute myocardial infarction. Nat. J. Chem., 4, 625-637.
Varley, H.; Gowenlock, A.H.; Bell, M. (1980). "Practical Clinical Biochemistry". William Heinemann Medical Books LTD, London, Vol.1, pp. 222-225, 553-555.
Willard, H.H.; Meritt, L.L.; Dean, J.A. (1974). "Instrumental Methods of Analysis". 5th.ed., D. Van Nostrand Company, New York, pp. 350-388.
View Dimensions
View Altmetric
Save
Citation
View
Share